Vasbinder A, Anderson E, Shadid H, Berlin H, Pan M, Azam TU, Khaleel I, Padalia K, Meloche C, O’Hayer P, Michaud E, Catalan T, Feroze R, Blakely P, Launius C, Huang Y, Zhao L, Ang L, Mikhael M, Mizokami-Stout K, Pennathur S, Kretzler M, Loosen SH, Chalkias A, Tacke F, Giamarellos-Bourboulis EJ, Reiser J, Eugen-Olsen J, Feldman EL, Pop-Busui R, Hayek SS, Group IS, Hayek SS, Blakely P, Berlin H, Azam TU, Shadid H, Pan M, O’Hayer P, Meloche C, Feroze R, Padalia KJ, Anderson E, Perry D, Bitar A, Kaakati R, Huang Y, Zhao L, Reiser J, Samelko B, Hlepas A, Patel PP, Wang X, Eugen-Olsen J, Altintas I, Stauning M, Baltzer Houlind M, Lindstrom MB, Gamst-Jensen H, Hartmann LJ, Nehlin JO, Kallemose T, Parvaiz I, Rasmussen C, Andersen O, Tingleff J, Giamarellos-Bourboulis EJ, Adami ME, Solomonidi N, Tsilika M, Saridaki M, Lekakis V, Loosen SH, Luedde T, Keitel V, Chalkias A, Arnaoutoglou E, Pantazopoulos I, Laou E, Kolonia K, Skoulakis A, Tacke F, Tober-Lau P, Mohr R, Kurth F, Sander LE, Jochum C: Inflammation, hyperglycemia, and adverse outcomes in individuals with diabetes mellitus hospitalized for COVID-19. Diabetes Care 2022; 45: 692-700
September 21, 2022
